Christine Coyne

Christine Coyne currently serves as Chief Commercial Officer at Iterum Therapeutics plc since July 2025 and as Chief Executive Officer at CIA, LLC, where commercial advisory services are provided to C-suite executives and Boards of Directors. Previously, Christine held the position of Chief Commercial Advisor at BW Health Group from October 2024 to July 2025, and served as Chief Commercial Officer at Innoviva Specialty Therapeutics, Inc. from January 2023 to October 2024, focusing on sales management and executive leadership. Christine is also a member of WBL (Women Business Leaders of the US Health Care Industry Foundation) from September 2024 to July 2025. Educational background includes a BA in Spanish and Italian from West Chester University of Pennsylvania and an MBA in Business and Marketing from Eastern University.